Modafinil
Also known as: Provigil
Classification
Pharmaceutical
Regulatory Status
FDA-approved
Sources
1
Review
n/a
Overview
Modafinil is represented by its commonly described wakefulness-promoting agent mechanism. This conservative launch record supports search and overlap detection, not medical recommendation.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Benefits
People look up modafinil (Provigil) as a prescription wakefulness-promoting agent for labeled sleep-disorder sleepiness indications. Cognitive-enhancement use in healthy people is off-label and contested.
Interactions & cautions
Flagged in source data
Drug interactions
hormonal contraceptives — Potential additive or opposing effects may occur. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw